Foyston, Gordon, & Payne’s Teva Pharmaceuticals TEVA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-572,656	Closed	-$26.3M	–	78
2016 Q3	$26.3M	Sell	572,656 -21,925	-4%	-$1.14M	5.09%	3
2016 Q2	$29.9M	Buy	594,581 +26,305	+5%	+$1.4M	5.44%	2
2016 Q1	$30.4M	Sell	568,276 -969	-0.2%	-$56.9K	5.66%	2
2015 Q4	$37.4M	Buy	569,245 +103,030	+22%	+$6.37M	7.06%	1
2015 Q3	$31.2M	Sell	466,215 -183,986	-28%	-$11.9M	5.81%	1
2015 Q2	$38.4M	Buy	650,201 +13,628	+2%	+$841K	5.78%	1
2015 Q1	$39.7M	Buy	636,573 +10,571	+2%	+$615K	5.85%	1
2014 Q4	$20.9M	Buy	626,002 +4,051	+0.7%	+$226K	2.99%	9
2014 Q3	$33.4M	Sell	621,951 -52,937	-8%	-$2.8M	4.8%	2
2014 Q2	$35.4M	Buy	674,888 +313,877	+87%	+$16M	4.49%	1
2014 Q1	$19.1M	Sell	361,011 -474,988	-57%	-$22M	2.35%	13
2013 Q4	$33.5M	Buy	835,999 +55,415	+7%	+$2.18M	4.16%	2
2013 Q3	$29.5M	Buy	+780,584	New	+$30.4M	3.85%	3